» Articles » PMID: 38075953

Editorial: Novel Strategies for the Prevention and Treatment of Foam Cell Formation and Atherosclerosis

Overview
Authors
Affiliations
Soon will be listed here.
Citing Articles

Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process.

Saki N, Haybar H, Maniati M, Davari N, Javan M, Moghimian-Boroujeni B J Diabetes Metab Disord. 2024; 23(2):1687-1697.

PMID: 39610485 PMC: 11599683. DOI: 10.1007/s40200-024-01482-8.

References
1.
Tan C, Aziz M, Wang P . The vitals of NETs. J Leukoc Biol. 2020; 110(4):797-808. PMC: 9059135. DOI: 10.1002/JLB.3RU0620-375R. View

2.
Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V . Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015; 349(6245):316-20. PMC: 4854322. DOI: 10.1126/science.aaa8064. View

3.
McClellan M, Brown N, Califf R, Warner J . Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation. 2019; 139(9):e44-e54. DOI: 10.1161/CIR.0000000000000652. View

4.
Liu Y, Carmona-Rivera C, Moore E, Seto N, Knight J, Pryor M . Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis. Front Immunol. 2018; 9:1680. PMC: 6094966. DOI: 10.3389/fimmu.2018.01680. View

5.
Moore K, Koplev S, Fisher E, Tabas I, Bjorkegren J, Doran A . Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2). J Am Coll Cardiol. 2018; 72(18):2181-2197. PMC: 6522246. DOI: 10.1016/j.jacc.2018.08.2147. View